SCHEMBL724952

SCHEMBL724952

COC(=O)c1cc(-c2cc3nccc(-c4ccccc4)c3o2)cc(OC)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.43
JAK1 P23458 1/20 0.43
TYK2 P29597 1/20 0.43
TUBB4A P04350 5/20 0.42
TUBB P07437 5/20 0.42
TUBA3C P0DPH7 5/20 0.42
TUBA1B P68363 5/20 0.42
TUBA4A P68366 5/20 0.42
TUBB4B P68371 5/20 0.42
TUBB3 Q13509 5/20 0.42
TUBB2A Q13885 5/20 0.42
TUBB8 Q3ZCM7 5/20 0.42
TUBA3E Q6PEY2 5/20 0.42
TUBA1A Q71U36 5/20 0.42
TUBA1C Q9BQE3 5/20 0.42
TUBB6 Q9BUF5 5/20 0.42
TUBB2B Q9BVA1 5/20 0.42
TUBB1 Q9H4B7 5/20 0.42
ACHE P22303 1/20 0.41
PLK1 P53350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724989 0.92 PDE4C (0.47) JAK2JAK1TYK2TUBB4ATUBB
SCHEMBL722839 0.87 PDE4C (0.51) JAK2JAK1TYK2TUBB4ATUBB
SCHEMBL27920018 0.87 PDE4C (0.41) JAK2JAK1TYK2PDE4CPTGES
SCHEMBL723580 0.85 JAK2 (0.38) JAK2JAK1TYK2TUBB4ATUBB
SCHEMBL721518 0.85 PDE4C (0.43) JAK2JAK1TYK2PDE4CPTGES
SCHEMBL723959 0.85 HPGD (0.39) CYP1A1CYP1B1PTK2TP53MAPT
SCHEMBL724085 0.84 PDE4C (0.45) JAK2JAK1TYK2PDE4CPTGES
SCHEMBL722312 0.82 JAK2 (0.48) JAK2JAK1TYK2TUBB4ATUBB
SCHEMBL722753 0.81 NEK2 (0.47) JAK2JAK1TYK2TUBB4ATUBB
SCHEMBL10267299 0.81 MAPK1 (0.55) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB JAK2 14/4885JAK1 25/4885TYK2 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.